Xenotransplantation of baboon bone marrow cells: a historical review of the protocols as a possible treatment modality for HIV/AIDS.
Despite great advances and a significant understanding of HIV pathogenesis, no curative treatment modality currently exists. Since baboon bone marrow cells (BBMC) are believed to be resistant to the human immunodeficiency virus, researchers have recently transplanted BBMC into two patients with AIDS, a process known as xenotransplantation. The purpose of this paper is to provide a comparative analysis of human and baboon hematopoiesis, followed by a review of the pathophysiologic effects of the HIV on the human hematologic and immune systems. The two protocols implemented since 1994 are discussed, including an overview of the potential risks and benefits and implications for nursing practice.
Relf
M V
MV
Johns Hopkins University, Baltimore, MD, USA.
D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D017809:Fatal Outcome; D015658:HIV Infections / Q000451:nursing / Q000503:physiopathology* / Q000628:therapy; D006410:Hematopoiesis / Q000276:immunology*; D006801:Humans; D007962:Leukocytes / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010215:Papio / Q000276:immunology*; D010353:Patient Education as Topic; D018570:Risk Assessment; D014183:Transplantation, Heterologous / Q000009:adverse effects / Q000276:immunology*